|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Chlamydia Trachomatis IgG ELISA | Anti-Ustekinumab (Stelara®) ELISA | a-Synuclein ELISA Assay | NSE ELISA Assay | Triiodothyronine (Total) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05033 | TM09036 | 27740 | 420-85 | IB19107N |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgG antibodies in serum or plasma directed against Chlamydia trachomatis. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Solid phase sandwich ELISA for the determination Human a-Synuclein in serum, EDTA plasma, CSF and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of NSE (Neuron-Specific Enolase) in human serum. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of total T3 (Triiodothyronine) in human serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Chlamydia Trachomatis IgG | sAPP Total | Histamine | Complement Factor P (Properdin) | Triiodothyronine (Total) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Blood Plasma, Urine | Human serum or EDTA plasma. | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | Anti-Ustekinumab (Stelara®) | 0.16 to 10.00 ng/mL | 7.5 to 138.0 µg/L | 0.5 to 7.5 ng/mL |
| Sensitivity | > 93% | 0.06 ng/mL | Plasma: 0.12 ng/mL; Urine: 0.30 ng/mL. | Inquire | Inquire |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 2 hour, 30 min. total incubation time. | Overnight + 1 hr 30 min. (incubation) | 1 hrs 30 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |